par Hildebrand, Jerzy
;Sahmoud, Tarek;Mignolet, François
;Brucher, Jean Marie;Áfra, Dénes;EORTC Brain Tumour Group,
Référence Neurology, 44, 8, page (1479-1483)
Publication Publié, 1994-08
;Sahmoud, Tarek;Mignolet, François
;Brucher, Jean Marie;Áfra, Dénes;EORTC Brain Tumour Group, Référence Neurology, 44, 8, page (1479-1483)
Publication Publié, 1994-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Hildebrand, Jerzy; Sahmoud, Tarek; Mignolet, François; Brucher, Jean Marie; Áfra, Dénes; EORTC Brain Tumour Group, |
| Informations sur la publication: | Neurology, 44, 8, page (1479-1483) |
| Statut de publication: | Publié, 1994-08 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adult |
| Aged | |
| Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Brain Neoplasms -- drug therapy | |
| Brain Neoplasms -- mortality | |
| Carmustine -- administration & dosage | |
| Chemotherapy, Adjuvant | |
| Female | |
| Glioma -- drug therapy | |
| Glioma -- mortality | |
| Humans | |
| Male | |
| Middle Aged | |
| Mitolactol -- administration & dosage | |
| Survival Analysis | |
| Note générale: | Clinical Trial |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0028-3878 |
| info:scp/0028107037 | |
| info:pmid/8058153 |



